Alliance for Advanced Therapies to officially launch at BIO-Europe Spring® 2012
Leading life science partnering event to be a springboard for cell therapy, regenerative medicine and other potentially life-saving advanced therapeutics in Europe
Zurich, Switzerland and Amsterdam, The Netherlands – March 7, 2012:
EBD Group today announced that the Alliance for Advanced Therapies (AAT) will launch at the BIO-Europe Spring® 2012 partnering event, held in Amsterdam March 19–21, 2012 at the Amsterdam RAI Convention Center. The Alliance for Advanced Therapies is a new organization devoted to supporting cell therapy, regenerative medicine and other potentially life-saving advanced therapeutics in Europe. As the European Chapter of the global Alliance for Regenerative Medicine, the AAT will use the large presence of dealmakers and decision makers from the global life science industry at BIO-Europe Spring to help springboard support for emerging therapies in Europe.
The launch of AAT will be marked by a State of the Industry presentation by Eduardo Bravo, CEO of TiGenix and Michael Hunt, CEO of ReNeuron on March 21, 15:30 CET.
The launch is a prelude to the Advanced Therapies Summit 2012 in Amsterdam on March 22, following BIO-Europe Spring 2012 (separate registration needed). The Advanced Therapies Summit brings together a large number of executives from big pharma, smaller companies, academic institutes and other organizations involved in advanced therapies from the US and Europe. The summit will address the most important topics on the path of commercialization of advanced therapies with discussion leaders from companies like Aldagen, Athersys, J&J, Organovo, Pfizer, ReNeuron, Shire and TiGenix.
"Advanced therapies, such as regenerative medicine or cell therapy, have the power to transform healthcare with breakthrough therapies where conventional approaches do not provide adequate solutions. It is vital that this sector gains the financial, scientific, political and regulatory support to deliver on the promise of this next wave of the biotech industry," said Rob Janssen, Secretary-General of the AAT. "The AAT will be a vital and credible champion for this growing sector in Europe, and worldwide through the Alliance for Regenerative Medicine."
Partnering is generated by partneringONE®, the leading conference partnering system for the life sciences. There are thousands of partnering opportunities now ready for your engagement on the system. Information on how to create a partnering profile and begin efficiently identifying and requesting meetings with potential collaborators can be found at
The online registration deadline for BIO-Europe Spring is March 16, 2012, 13:00 CET, after which all registrations will be handled on site. Information on the conference and registration details can be found online at http://www.ebdgroup.com/bes/registration/index.php.
For more information about BIO-Europe Spring, go to www.ebdgroup.com/bes/index.php.
For more information on the Alliance for Advanced Therapies go to http://www.allianceat.org.
For more information on the Advanced Therapies Summit 2012 go to http://www.advancedtherapiessummit.eu.
Additional links and information:
Follow BIO-Europe Spring 2012 on Twitter: twitter.com/EBDgroup (hashtag: #BES12)
LinkedIn Event site: http://linkd.in/uA0L0x
About EBD Group
EBD Group is the leading partnering firm for the global life science industry. Since 1993, biotech, pharma and medical device companies have leveraged EBD Group's partnering conferences, technology and services to identify business opportunities and develop strategic relationships essential to their success.
EBD Group's conferences are run with the support of leading corporations and international trade associations and include:
- BIO-Europe® and BIO-Europe Spring®, Europe's largest life science partnering conferences, supported by the Biotechnology Industry Organization (BIO)
- BioPharm America™, the fastest growing partnering event in North America
- Biotech Showcase™, a unique forum in San Francisco for presenting to investors and business development executives, co-produced with Demy-Colton Life Science Advisors
- BioEquity Europe, the investor conference co-organized with BioCentury Publications and BIO
- ChinaBio® Partnering Forum, the first dedicated biotech/pharma partnering conference in China, co-produced with ChinaBio® LLC
- EuroMedtech™, EBD Group's partnering event for the innovative medical technology industry
- Partnering for Global Impact®, a new partnering conference providing an innovative forum to partner, identify and generate social and philanthropic investment and funding opportunities
EBD Group's sophisticated web-based partnering service, partneringONE®, is used as the partnering engine at numerous third-party events around the world, and partnering360® is the open online community of life science dealmakers that enhances partnering experiences throughout the year.
Outside of the conference format, EBD Group's consultants provide hands-on assistance for firms seeking to in- or out-license products and technologies.
EBD Group has offices in the USA and Europe.
Additional links and information:
Follow EBD Group on Twitter: twitter.com/ebdgroup
For more information please visit www.ebdgroup.com.